Board of Directors

Harry Hyman

Non-executive Chair

Election to the Board - Harry Hyman founded the Company in 1996 and served on the Board as Managing Director from that time and represented the former adviser to the Company, Nexus Tradeco Limited (“Nexus”), on the Board. On completion of the internalisation on 5 January 2021, Harry was appointed as Chief Executive Officer. Shareholders approved his appointment as Non-executive Chair with effect from the end of the 2024 AGM. The Board believes that Harry’s appointment continues to be in the best interests of the Group and all of its stakeholders, particularly as his knowledge and expertise gained over nearly 30 years in the primary care property sector will continue to be invaluable and highly relevant to the Group’s future success. The Board has determined that the term will be a maximum of three years from the 2024 AGM.

Career - Harry graduated from Cambridge University and trained as a Chartered Accountant and Corporate Treasurer. He established the Company in 1996 and was the Managing Director of Nexus Tradeco Limited, which until 5 January 2021 was the Adviser to PHP.

He is a Fellow of the Institute of Chartered Accountants in England and Wales, and a Fellow of the Association of Corporate Treasurers.

Skills, competence and experience - Harry has extensive experience in investing in the primary healthcare sector, having developed the Company’s business from inception over 20 years ago to its current position with an investment portfolio of over £2.8 billion. He also brings entrepreneurial flair to the Board having established a number of successful private companies.

Other listed directorships - Non-executive Chair of Biopharma Credit PLC, an externally managed investment trust which invests in the fast-growing science industry and is listed on the London Stock Exchange.

Mark Davies

Chief Executive Officer

Election to the Board - Mark Davies was appointed to the Board from the 2024 AGM.

Career - Mark was a Co-founder Director of NewRiver REIT plc (“NewRiver”) in 2009 and played an important role in taking NewRiver from IPO into the FTSE 250 Index in seven years. He was CFO of NewRiver for over twelve years and, alongside his role as CFO, was also CEO/Executive Chair of Hawthorn Leisure Limited (“Hawthorn”) for five years. Mark stood down from the board of NewRiver following the successful sale of Hawthorn in July 2021 to private equity at a premium price.

Skills, competence and experience - Mark has considerable capital markets experience and over the last 14 years has raised over £3 billion of equity and debt in public and private markets.

Other listed directorships - Senior Independent Director of Palace Capital plc.

Richard Howell

Chief Financial Officer

Election to the Board - Richard Howell was appointed to the Board from 31 March 2017, having joined Nexus on 13 March 2017, and following completion of the internalisation of the advisory and management functions previously carried out by Nexus, he was appointed Chief Financial Officer.

Career - Richard is a Chartered Accountant and has over 20 years’ experience working with London-listed commercial property companies, gained principally with LondonMetric Property plc and Brixton plc. Richard was part of the senior management team that led the merger of Metric Property Investments plc and London & Stamford Property plc in 2013 to create LondonMetric Property plc. In May 2022 he was appointed as a Non-executive Director at Life Science REIT plc, an AIM-listed, externally managed real estate investment trust.

Skills, competence and experience - Richard has extensive finance experience, having previously held senior accounting positions within listed property companies operating across the UK. Whilst working for LondonMetric Property plc and Brixton plc, he has been involved in over £5 billion of property transactions.

Other listed directorships - Senior Independent Non-executive Director and Audit Chair of Life Science REIT plc.

Laure Duhot

Independent Non-executive Director

Election to the Board – Laure Duhot was appointed to the Board from 14 March 2019 following completion of the merger with MedicX Fund Limited. She is Chair of the ESG Committee.

Career – Laure started her career in the investment banking sector and has developed a focus on the property sector. She has held senior roles at Lehman Brothers, Macquarie Capital Partners, Sunrise Senior Living Inc., Grainger plc and Lendlease.

Skills, competence and experience – Laure brings over 30 years of senior executive level experience in the investment banking and property sectors, specialising in alternative real estate assets, and has been a Non-executive Director at a number of funds and property companies.

Other listed directorships – Non-executive Director of Safestore Holdings plc and NB Global Monthly Income Fund Limited (until July 2024).

Independent Non-executive - Yes

Ian Krieger

Senior Independent Non-executive Director

Election to the Board - Ian Krieger was elected a Director at the 2018 Annual General Meeting, having been appointed to the Board in February 2018, and is Chair of the Audit Committee.

Career - Ian is a Chartered Accountant and was a Partner and Vice-Chair at Deloitte until his retirement in 2012.

Skills, competence and experience - Ian qualified as and practised as a Chartered Accountant and brings a wealth of recent financial experience to the Board as well as his experience as Chair of the audit committees of two other UK-listed companies in the property sector (having been Senior Independent Non-executive Director and Chair of the audit committee at both Safestore Holdings plc and Capital & Regional plc until his retirement in 2024 as noted below).

Other listed directorships - Safestore Holdings plc and Capital & Regional plc (until March and June 2024, respectively).

Independent Non-executive - Yes

Ivonne Cantú

Independent Non-executive Director

Election to the Board - Ivonne Cantú was appointed to the Board from 1 January 2022.

Career - Ivonne has significant public company experience having spent over 20 years advising listed businesses. She is currently the Director of Investor Relations, Communications and Sustainability as well as a member of the executive management team and the sustainability committee of Benchmark Holdings plc, a biotechnology aquaculture company. She is also a Non-executive Director and Chair of the remuneration committee at Creo Medical Group plc and a Trustee of two non-profit charitable organisations, La Vida and Info Latinos, and TEH Advisory Board.

Skills, competence and experience - Prior to taking up her position at Benchmark Holdings plc, Ivonne spent 13 years as a Senior Corporate Finance Adviser at Cenkos Securities plc, and prior to that seven years as an Investment Banker at Merrill Lynch. She has a degree in engineering from the Universidad Panamericana in Mexico City and an MBA from the Wharton School of Business at the University of Pennsylvania.

Other listed directorships - Creo Medical Group plc.

Independent Non-executive - Yes

Dr Bandhana (Bina) Rawal

Independent Non-executive Director

Election to the Board - Bina Rawal was appointed to the Board from 27 February 2024.

Career - Bina is a medical professional with 25 years’ senior executive experience in healthcare, including with blue chip pharmaceutical companies such as Roche and global research funding charity Wellcome Trust. She is currently Senior Independent Director at Worldwide Healthcare Trust plc, a FTSE 250-listed investment trust specialising in healthcare and life sciences companies where she is board lead for ESG and chairs the nominations committee.

Skills, competence and experience - Bina has a wide breadth of experience spanning patient care, digital and population health, ESG, strategy, partnerships and EDI, alongside extensive networks in UK healthcare through her senior level executive and non-executive roles to date in large, complex organisations within the public, private and not-for-profit sectors.

Other listed directorships - Worldwide Healthcare Trust plc.

Independent Non-executive - Yes